Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial

被引:6
|
作者
Sun, Yuxiu [1 ,5 ]
Zhao, Hong [2 ]
Ye, Yongming [1 ]
Nie, Wenbin [3 ]
Bai, Wenjing [4 ]
Liu, Jia [4 ]
Li, Sinuo [1 ]
Wang, Fang [2 ]
Han, Mingjuan [2 ]
He, Liyun [4 ]
机构
[1] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing 100053, Peoples R China
[2] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing 100700, Peoples R China
[3] Mentougou Hosp TCM, Beijing 102300, Peoples R China
[4] China Acad Chinese Med Sci, Beijing 100700, Peoples R China
[5] Hubei Univ Chinese Med, Wuhan 430061, Peoples R China
关键词
Acupuncture; Warm needling; Persistent allergic rhinitis; RCT; Study protocol; QUALITY-OF-LIFE; DOUBLE-BLIND; ACUPUNCTURE; ASTHMA; QUESTIONNAIRE; IMMUNOTHERAPY; MULTICENTER; LORATADINE; ADULTS; COST;
D O I
10.1186/s13063-016-1432-z
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Many previous studies have shown the potential therapeutic effect of acupuncture for allergic rhinitis. Most of these studies, however, were limited by the short duration of observations and lack of sham acupuncture as the control group. Our preliminary experiments showed that the use of a warm needling achieved a much more persistent effect in the treatment of allergic rhinitis (AR) compared with simple acupuncture therapy. Hence, we have designed a multicenter, randomized controlled trial (RCT) in which the first-line medication loratadine will be used as the control group, and the effect of warm needling therapy will be evaluated through long-term observation. Methods/design: The trial is designed as a multicenter, parallel-group, randomized, single-blinded (outcome assessors), non-inferiority trial. A total of 98 patients with persistent AR will be randomly assigned into two groups. Patients in the treatment group will be treated with warm needling at GV14 and acupuncture at EX-HN3, ST2, LI20, EX-HN8, GV23, LU7, LU5 and LI4 three times a week, for a total of 4 weeks. Patients in the control group will be treated with oral loratadine 10 mg/day for 4 weeks. The primary outcome will be the change in the Total Nasal Symptom Score (TNSS) from baseline to that at 6 months after treatment during the follow-up period. The secondary outcomes will include the Total Non-nasal Symptom Score and the Rhinoconjunctivitis Quality of Life Questionnaire, changes in the TNSS from baseline to that at 2 and 4 weeks during treatment, and 3 months after treatment during the follow-up period. Outcomes will be measured at 2 and 4 weeks, and 3 and 6 months after treatment. Any side effects of treatment will be observed and recorded. Discussion: We expect that the study results will provide evidence to determine the effects of warm needling compared with loratadine. Our final goal of the study is to evaluate the difference in the short-term and long-term effects between the two therapeutic methods, especially the long-term effect of warm needling.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial
    Yuxiu Sun
    Hong Zhao
    Yongming Ye
    Wenbin Nie
    Wenjing Bai
    Jia Liu
    Sinuo Li
    Fang Wang
    Mingjuan Han
    Liyun He
    [J]. Trials, 17
  • [2] Efficacy and Safety of Sanfu Herbal Patch at Acupoints for Persistent Allergic Rhinitis: Study Protocol for a Randomized Controlled Trial
    Chen, Xiankun
    Lu, Chuanjian
    Stalsby-Lundborg, Cecilia
    Li, Yunying
    Li, Xiaoyan
    Sun, Jian
    Ouyang, Wenwei
    Li, Geng
    Su, Guobin
    Lu, Liming
    Fu, Wenbin
    Wen, Zehuai
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [3] Efficacy and safety of electric heating moxibustion for perennial allergic rhinitis: protocol for a randomized controlled trial
    Chan-Yung Jung
    Min-Jin Cho
    Ha-Ra Kang
    Seung-Ug Hong
    Won-Suk Sung
    Eun-Jung Kim
    [J]. Trials, 20
  • [4] Efficacy and safety of electric heating moxibustion for perennial allergic rhinitis: protocol for a randomized controlled trial
    Jung, Chan-Yung
    Cho, Min-Jin
    Kang, Ha-Ra
    Hong, Seung-Ug
    Sung, Won-Suk
    Kim, Eun-Jung
    [J]. TRIALS, 2019, 20 (1)
  • [5] Effectiveness and safety of ear acupuncture for allergic rhinitis A protocol of randomized controlled trial
    Ding, Xiaojun
    Huang, Shufen
    Tang, Yajun
    Lin, Jia
    [J]. MEDICINE, 2021, 100 (12) : E24943
  • [6] Efficacy and safety of herbal steam bath in allergic rhinitis: a randomized controlled trial
    Tungsukruthai, Parunkul
    Nootim, Preecha
    Worakunphanich, Wiwan
    Tabtong, Nareerat
    [J]. JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2018, 16 (01): : 39 - 44
  • [7] Efficacy and safety of herbal steam bath in allergic rhinitis: a randomized controlled trial
    Parunkul Tungsukruthai
    Preecha Nootim
    Wiwan Worakunphanich
    Nareerat Tabtong
    [J]. Journal of Integrative Medicine, 2018, 16 (01) : 39 - 44
  • [8] Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
    Lee, Su Won
    Choi, Jin Kwan
    Lyu, Yee Ran
    Yang, Won Kyung
    Kim, Seung Hyung
    Kim, Je Hyun
    Kim, Si Yeon
    Kang, Weechang
    Jung, In Chul
    Lee, Beom Joon
    Choi, Jun Yong
    Kim, Taesoo
    Park, Yang Chun
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [9] Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
    Lee, Su Won
    Choi, Jin Kwan
    Lyu, Yee Ran
    Yang, Won Kyung
    Kim, Seung Hyung
    Kim, Je Hyun
    Kim, Si Yeon
    Kang, Weechang
    Jung, In Chul
    Lee, Beom Joon
    Choi, Jun Yong
    Kim, Taesoo
    Park, Yang Chun
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [10] Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
    Lee, Su Won
    Choi, Jin Kwan
    Lyu, Yee Ran
    Yang, Won Kyung
    Kim, Seung Hyung
    Kim, Je Hyun
    Kim, Si Yeon
    Kang, Weechang
    Jung, In Chul
    Lee, Beom Joon
    Choi, Jun Yong
    Kim, Taesoo
    Park, Yang Chun
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022